Â¥
7.81
Oct 18
New Key Statistics Module, Z-Score and F-Score
SZSE:002365 Key Ratios
Market Cap ¥ M | 2,257.27 |
Enterprise Value ¥ M | 1,412.31 |
P/E(ttm) | -- |
PE Ratio without NRI | 111.57 |
Forward PE Ratio | -- |
Price/Book | 1.15 |
Price/Sales | 2.82 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 1.43 |
Revenue (TTM) ¥ M | 820.00 |
EPS (TTM) ¥ | -0.06 |
Beneish M-Score | -2.32 |
10-y EBITDA Growth Rate % | 13.80 |
5-y EBITDA Growth Rate % | -8.70 |
y-y EBITDA Growth Rate % | -95.10 |
EV-to-EBIT | 1,112.93 |
EV-to-EBITDA | 1,112.93 |
PEG | -- |
Shares Outstanding M | 294.68 |
Net Margin (%) | -1.95 |
Operating Margin % | 0.38 |
Pre-tax Margin (%) | 0.10 |
Quick Ratio | 4.52 |
Current Ratio | 4.87 |
ROA % (ttm) | -0.67 |
ROE % (ttm) | -0.79 |
ROIC % (ttm) | -10.54 |
Dividend Yield % | 1.31 |
Altman Z-Score | 6.40 |
SZSE:002365 Number of Guru Trades
SZSE:002365 Volume of Guru Trades
Gurus Latest Trades with SZSE:002365
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002365 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Qianjiang Yongan Pharmaceutical Co Ltd Insider Transactions
No Available Data